TELA Bio, Inc.
TELA
$0.57
-$0.05-8.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.24% | 9.14% | 25.52% | 11.55% | 3.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.24% | 9.14% | 25.52% | 11.55% | 3.83% |
| Cost of Revenue | 10.83% | 10.34% | 21.82% | 14.33% | 19.97% |
| Gross Profit | 22.39% | 8.58% | 27.15% | 10.29% | -3.44% |
| SG&A Expenses | 4.15% | -4.86% | 3.26% | -4.24% | -17.30% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.82% | -0.28% | 5.85% | -0.06% | -11.18% |
| Operating Income | 20.42% | 19.34% | 21.51% | 15.59% | 31.96% |
| Income Before Tax | 4.88% | 17.06% | 21.51% | -98.06% | 27.45% |
| Income Tax Expenses | 200.69% | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1.81% | 17.06% | 21.25% | -98.98% | 28.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.81% | 17.06% | 21.25% | -98.98% | 28.56% |
| EBIT | 20.42% | 19.34% | 21.51% | 15.59% | 31.96% |
| EBITDA | 20.59% | 19.73% | 22.17% | 16.16% | 33.25% |
| EPS Basic | 23.89% | 54.89% | 57.19% | -8.03% | 56.34% |
| Normalized Basic EPS | 33.65% | 54.88% | 57.31% | 54.02% | 55.65% |
| EPS Diluted | 23.89% | 54.89% | 57.19% | -8.03% | 56.34% |
| Normalized Diluted EPS | 33.65% | 54.88% | 57.31% | 54.02% | 55.65% |
| Average Basic Shares Outstanding | 28.97% | 83.87% | 83.94% | 84.17% | 63.64% |
| Average Diluted Shares Outstanding | 28.97% | 83.87% | 83.94% | 84.17% | 63.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |